- Home
- PSIG vs NEUP Comparison
PSIG vs NEUP Comparison
Compare PSIG & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIG
- NEUP
- Stock Information
- Founded
- PSIG 1993
- NEUP 1996
- Country
- PSIG Hong Kong
- NEUP United States
- Employees
- PSIG N/A
- NEUP N/A
- Industry
- PSIG
- NEUP
- Sector
- PSIG
- NEUP
- Exchange
- PSIG NYSE
- NEUP Nasdaq
- Market Cap
- PSIG 11.3M
- NEUP 9.3M
- IPO Year
- PSIG N/A
- NEUP N/A
- Fundamental
- Price
- PSIG $0.42
- NEUP $5.04
- Analyst Decision
- PSIG
- NEUP Strong Buy
- Analyst Count
- PSIG 0
- NEUP 1
- Target Price
- PSIG N/A
- NEUP $21.00
- AVG Volume (30 Days)
- PSIG 125.2K
- NEUP 21.4K
- Earning Date
- PSIG 12-12-2024
- NEUP 05-15-2025
- Dividend Yield
- PSIG N/A
- NEUP N/A
- EPS Growth
- PSIG N/A
- NEUP N/A
- EPS
- PSIG N/A
- NEUP N/A
- Revenue
- PSIG $112,317,226.00
- NEUP $662,715.00
- Revenue This Year
- PSIG N/A
- NEUP N/A
- Revenue Next Year
- PSIG N/A
- NEUP N/A
- P/E Ratio
- PSIG N/A
- NEUP N/A
- Revenue Growth
- PSIG N/A
- NEUP N/A
- 52 Week Low
- PSIG $0.38
- NEUP $2.12
- 52 Week High
- PSIG $4.20
- NEUP $15.24
- Technical
- Relative Strength Index (RSI)
- PSIG N/A
- NEUP N/A
- Support Level
- PSIG N/A
- NEUP N/A
- Resistance Level
- PSIG N/A
- NEUP N/A
- Average True Range (ATR)
- PSIG 0.00
- NEUP 0.00
- MACD
- PSIG 0.00
- NEUP 0.00
- Stochastic Oscillator
- PSIG 0.00
- NEUP 0.00
About PSIG PS INTERNATIONAL GROUP LTD
PS International Group Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports, and local transportation and warehousing-related services such as repackaging, labeling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing to meet the requirement of customers.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.